在多发性骨髓瘤患者中遵守多学科瘤委员会建议
Valérie Gennheimer1, Dilara Akhoundova1, Michèle Hoffmann1
1Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Cancers
|April 26, 2025
概括
多学科骨髓瘤瘤委员会 (MMTB) 的建议显示,对诊断和治疗的坚持很高,但临床试验招生率很低,通常是由于患者的选择. 评估坚持是优化癌症护理的关键.
科学领域:
- 在瘤学瘤学.
- 临床实践指南 临床实践指南
- 医疗保健管理的管理
背景情况:
- 多学科瘤委员会 (MTB) 的建议是个性化癌症护理的标准.
- 评估遵守MTB建议对于评估其实际影响至关重要.
- 这项研究追溯分析了多学科骨髓瘤瘤委员会 (MMTB) 建议的遵守情况.
研究的目的:
- 确定MMTB诊断,治疗和临床试验招生建议的遵守率.
- 确定导致不遵守MMTB建议的因素.
- 评估MMTBs对临床试验招生建议的实施情况.
主要方法:
- 在MMTBs讨论的连续患者病例的回顾性审查.
- 数据收集于2023年1月1日至12月31日,在瑞士伯尔尼大学医院.
- 通过将临床记录与MMTB建议进行比较来评估遵守.
主要成果:
- 总体上,对MMTB建议的遵守率为86% (251/292),完全遵守率为84%.
- 诊断/治疗的不遵守是临床上合理的;患者的决定是主要原因.
- 临床试验招生建议 (36%) 仅在32%的病例中得到实施,患者的决定是主要因素.
结论:
- 观察到高度遵守MMTB诊断和治疗建议.
- 临床试验招生遵守率仍然低于最佳水平,受患者偏好的影响很大.
- 建议定期评估遵守情况,并将患者的偏好纳入MMTB讨论中.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.0K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.7K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K